SCHEMBL5849607

SCHEMBL5849607

Cn1nc(-c2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)O)cc1-c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 12/20 0.49
PSEN2 P49810 12/20 0.49
APH1B Q8WW43 12/20 0.49
NCSTN Q92542 12/20 0.49
APH1A Q96BI3 12/20 0.49
PSENEN Q9NZ42 12/20 0.49
GRIA2 P42262 2/20 0.42
HDAC6 Q9UBN7 2/20 0.38
NR1H2 P55055 2/20 0.38
NR1H3 Q13133 1/20 0.38
ASIC1 P78348 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026218 0.88 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1023750 0.85 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1024457 0.85 PSEN1 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1024325 0.80 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14079223 0.77 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14079225 0.73 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14079222 0.72 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14079229 0.69 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14097316 0.68 PSEN1 (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14019433 0.67 PSEN1 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144910-B2 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors MERCK SHARP & DOHME LIMITED (GB) 2006-12-05 US disclosed
US-20060069147-A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors MERCK SHARP & DOHME LTD. (GB) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069147-A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors BACE1, GSAP, BACE2 PSEN1 4/4885PSEN2 6/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.